Sanofi (SNY) extends its offer for the outstanding shares of Genzyme (GENZ) to April 1 from...

|About: Sanofi (SNY)|By:, SA News Editor

Sanofi (SNY) extends its offer for the outstanding shares of Genzyme (GENZ) to April 1 from March 16. Meanwhile, other biotech firms focused on rare diseases say the Sanofi-Genzyme deal puts many peers into play as takeover targets.